Substantia Nigra Susceptibility‐To‐Volume Ratio Derived From QSM as a Marker for Discrimination of Progressive Supranuclear Palsy From Parkinson's Disease and Multiple System Atrophy
Journal of Magnetic Resonance Imaging · 2026-12 · 64 (6) · 1677-1689
DOI: 10.1002/jmri.70459 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Magnetic Resonance Imaging, online erschienen am 20.07.2026. Verfasst von Huseyin Enes Candan und 13 weiteren Autor:innen. Beteiligte Einrichtung: Graduate School of Health Science and Technology, Ulsan National Institute of Science and Technology, Ulsan, Republic of Korea. Hauptthemen laut MEDLINE: Supranuclear Palsy, Progressive, Multiple System Atrophy, Substantia Nigra, Magnetic Resonance Imaging. Die Arbeit nennt 33 Literaturangaben. Gefördert von: National Research Foundation of Korea, Korea National Research Council of Science & Technology, Asan Institute for Life Sciences, Asan Medical Center.
Abstract (Originalsprache)
Background
Progressive supranuclear palsy (PSP) is both an underdiagnosed and a frequently misdiagnosed disorder. To remedy these diagnostic limitations, MRI has been used to investigate brain morphology to differentiate PSP from Parkinson's disease (PD) and multiple system atrophy (MSA). However, while nigrostriatal degeneration and tau aggregation are prominent in PSP, and result in iron accumulation and atrophy in the region, substantia nigra (SN) atrophy remains an underexplored diagnostic marker.
Purpose
To investigate the diagnostic utility of QSM‐derived SN parameters for PSP. Study Type Retrospective. Population 123 (59 Males/64 Females) PD patients, 48 (26 M/22 F) MSA patients, and 22 (11 M/11 F) PSP patients were included in the main dataset. MSA patients include 20 parkinsonian type (MSA‐P) (11 M/9 F) and 18 cerebellar type (MSA‐C) (9 M/9 F) of MSA with 10 undetermined subtype. The external validation set included 12 (6 M/6 F) healthy controls, 13 PD (7 M/6 F), and 10 PSP (6 M/4 F) patients. Field Strength and Sequence 3 T, MPRAGE T 1 ‐weighted imaging and multi‐echo gradient echo imaging (mGRE) for QSM. Assessment Group level differences of SN volume, magnetic susceptibility, and susceptibility‐to‐volume ratio (SVR) among PSP, PD, and MSA groups, and these metrics' differentiating power are measured. Bivariate logistic regression with T 1 ‐based morphological markers alongside SN metrics is performed. Statistical Tests Mann–Whitney U test for group comparisons. Receiver operating characteristic analysis with bootstrapping. p < 0.05 after Bonferroni correction is defined as statistically significant result.
Results
The SN SVR was significantly higher in the PSP group compared to the MSA group and the MSA‐P group. Moreover, using pons measurements with SN SVR in a bivariate model resulted in the highest differentiation between the PSP and MSA groups (AUC = 0.88, 95% CI: [0.78–0.95]), particularly driven by the increased differentiation between the PSP and MSA‐P groups (AUC = 0.88, 95% CI: [0.75–0.98]). External validation supported the generalizability of SN SVR, yielding 100% sensitivity and 80% specificity for differentiating PSP from HC and PD. Data Conclusion QSM‐based SN morphometry can complement T 1 ‐weighted imaging for Parkinsonism assessment. Evidence Level 3. Technical Efficacy Stage 2.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Graduate School of Health Science and Technology, Ulsan National Institute of Science and Technology, Ulsan, Republic of Korea.
- Department of Neurology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea.
- Department of Biomedical Engineering, Ulsan National Institute of Science and Technology, Ulsan, Republic of Korea.
- School of Biomedical Engineering, Jimma Institute of Technology, Jimma University, Jimma, Ethiopia.
- Athinoula A. Martinos Center for Biomedical Imaging, Department of Radiology, Massachusetts General Hospital, Charlestown, Massachusetts, USA.
- Department of Neurology, Pusan National University School of Medicine, Pusan National University Yangsan Hospital, Yangsan, Republic of Korea.
ORCID-Profile: Huseyin Enes Candan, Nepes Myratgeldyyev, Abel Worku Tessema, Hansol Lee, Jae-Hyeok Lee, Grace Yoojin Lee, Sun Ju Chung, HyungJoon Cho
Förderung
- National Research Foundation of Korea
- Korea National Research Council of Science & Technology
- Asan Institute for Life Sciences, Asan Medical Center
Zitieren
APA
Candan, H. E., Jo, S., Myratgeldyyev, N., Tessema, A. W., Lee, H., Lee, J. H., Lee, H., Lee, G. Y., Suh, C. H., Ryu, J., Chung, S. J., Park, K., Lee, E. J., & Cho, H. (2026). Substantia Nigra Susceptibility‐To‐Volume Ratio Derived From QSM as a Marker for Discrimination of Progressive Supranuclear Palsy From Parkinson's Disease and Multiple System Atrophy. Journal of Magnetic Resonance Imaging, 64(6), 1677-1689. https://doi.org/10.1002/jmri.70459
Vancouver
Candan HE, Jo S, Myratgeldyyev N, Tessema AW, Lee H, Lee JH, et al. Substantia Nigra Susceptibility‐To‐Volume Ratio Derived From QSM as a Marker for Discrimination of Progressive Supranuclear Palsy From Parkinson's Disease and Multiple System Atrophy. Journal of Magnetic Resonance Imaging. 2026;64(6):1677-1689. doi:10.1002/jmri.70459
BibTeX
@article{Candan2026,
author = {Candan, Huseyin Enes and Jo, Sungyang and Myratgeldyyev, Nepes and Tessema, Abel Worku and Lee, Hansol and Lee, Jae-Hyeok and Lee, Hyoyoung and Lee, Grace Yoojin and Suh, Chong Hyun and Ryu, Jihong and Chung, Sun Ju and Park, Kyemyung and Lee, Eun-Jae and Cho, HyungJoon},
title = {Substantia Nigra Susceptibility‐To‐Volume Ratio Derived From QSM as a Marker for Discrimination of Progressive Supranuclear Palsy From Parkinson's Disease and Multiple System Atrophy},
journal = {Journal of Magnetic Resonance Imaging},
year = {2026},
volume = {64},
number = {6},
pages = {1677--1689},
doi = {10.1002/jmri.70459}
}
EUVIMED